ストックスクリーナーアプリを入手
4.51
0.66%
-0.03
アフターアワーズ：
4.50
-0.010
-0.22%
前日終値:
$4.54
開ける：
$4.54
24時間の取引高:
32,116
Relative Volume:
0.01
時価総額：
$8.66M
収益：
-
当期純損益:
-
株価収益率:
-
EPS:
-
ネットキャッシュフロー:
-
1週間 パフォーマンス:
+0.22%
1か月 パフォーマンス:
-57.65%
6か月 パフォーマンス:
+15.35%
1年 パフォーマンス:
+0.00%
1日の値動き範囲:
$4.33
$4.622
1週間の範囲:
$4.20
$4.8384
52週間の値動き範囲:
$2.70
$18.00
Quantum Biopharma Ltd Stock (QNTM) Company Profile
QNTM を他の銘柄と比較する
| 株式 | 価格 | 時価総額 | 収益 | 当期純利益 | 現金流量 | EPS |
|---|---|---|---|---|---|---|
QNTM
Quantum Biopharma Ltd
|
4.51 | 8.66M | 0 | 0 | 0 | 0.00 |
|
ZTS
Zoetis Inc
|
160.06 | 71.67B | 9.26B | 2.49B | 2.30B | 5.47 |
|
TAK
Takeda Pharmaceutical Co Adr
|
15.03 | 47.44B | 30.25B | 1.37B | 5.08B | 0.4257 |
|
HLN
Haleon Plc Adr
|
10.19 | 46.08B | 14.35B | 1.85B | 0 | 0.4023 |
|
TEVA
Teva Pharmaceutical Industries Ltd Adr
|
16.46 | 18.86B | 16.54B | -1.64B | 749.00M | -1.45 |
|
ITCI
Intra Cellular Therapies Inc
|
131.36 | 13.97B | 612.78M | -86.37M | -62.91M | -0.87 |
Quantum Biopharma Ltd (QNTM) 最新ニュース
Quantum BioPharma Provides Corporate Update - Yahoo Finance
Quantum BioPharma Ltd (NASDAQ: QNTM): A Bold Step into the Future of Biopharmaceutical Innovation - openPR
Quantum BioPharma Completes Phase 1 Trial Of Lucid-21-302 For Multiple Sclerosis Treatment - Nasdaq
Quantum Biopharma up in U.S. Pre-market, Says Phase 1 Lucid-MS Trial Completed With no Safety Concerns - Marketscreener.com
Quantum BioPharma Reports No Safety Concerns for Lucid-MS Following Successful Phase 1 Trial - Nasdaq
Quantum Biopharma Announces Completion of the Phase 1 - GlobeNewswire
Quantum Biopharma Announces Completion of the Phase 1 Multiple Ascending Dose Clinical Trial for its Experimental Multiple Sclerosis Drug Lucid-21-302 - Niagara Falls Review
Quantum BioPharma's Novel MS Drug Successfully Completes Phase 1 Clinical Trial | QNTM Stock News - StockTitan
Quantum BioPharma expands cryptocurrency holdings By Investing.com - Investing.com Nigeria
Quantum BioPharma Continues to Diversify its Treasury with - GlobeNewswire
Quantum BioPharma Up 10% as Purchases Another US$1 Million Worth of Bitcoin, Other Cryptocurrencies - Marketscreener.com
Quantum BioPharma Soars 62% After Positive Clinical Trial Results for Unbuzzd Supplement - HPBL
Quantum BioPharma expands cryptocurrency holdings - Investing.com India
Quantum BioPharma Expands Cryptocurrency Holdings - TipRanks
Quantum BioPharma Continues to Diversify its Treasury with the Purchase of Another USD $1,000,000 Worth of Bitcoin (BTC) and Other Cryptocurrencies - The Manila Times
Quantum BioPharma Shares Soar 95% Following Breakthrough Clinical Trial Results for unbuzzd™ - HPBL
Best Cannabis Stocks To ConsiderFebruary 14th - MarketBeat
Quantum BioPharma unbuzzd™ Clinical Trial Results Show Promising Benefits in Alcohol Intoxication and Hangover Relief – market - HPBL
Quantum BioPharma (QNTM) Stock Soars 95% After Breakthrough Alcohol Metabolism Supplement Results - HPBL
Best Cannabis Stocks To Consider – February 14th - Defense World
Promising Cannabis Stocks To ConsiderFebruary 11th - MarketBeat
Top Cannabis Stocks To Consider – February 13th - Defense World
Quantum Biopharma Ltd (QNTM) 財務データ
Quantum Biopharma Ltd (QNTM) の財務データはありません。詳細については、他の銘柄を確認してください。
収益
当期純利益
現金流量
EPS
0.77%
0.63%
大文字化:
|
ボリューム (24 時間):